all updates

Partnerships update, August 2023

August 30, 2023

IME hub innovations: User accounts and personalized education journeys  

Here at SES, one of our priorities is to constantly refine and develop our offering – for both users and supporters. 

Our most recent updates across the portfolio of platforms included the introduction of translation functionality across our education, meaning we can supply content in over 100 languages, permitting truly global reach, as well as the introduction of the hub drug updates page, which allows users to access the latest drug and trial news as it is reported from our Twitter accounts. 

We are very excited to announce the introduction of user accounts across the suite of platforms, with the Lymphoma Hub being the first to see the roll-out later in Q4 of 2023. 

This innovation will ensure that the content can remain open-access and free but, for those who want it, users can start building learning journeys and bookmark and save articles of interest – enabling the creation of a personalized journey

Knowing more about the user’s interests will allow us to suggest further content to develop their learning journey. Importantly for us, it will provide essential profiles on our audience and what they need, allowing us to offer higher levels of learning outcomes as we will be able to link learning resources, reinforce education, and track outcomes. 

For more information around how your organization can support targeted education in Lymphoma and CLL, please contact: 


EULAR, ERA, & WCD – The SES Immunology Hubs go on their travels!  

Our global, open-access online platforms provide balanced, credible, and up-to-date medical education. In 2022, we successfully launched our first platforms within the immunology space: the Psoriasis and Psoriatic Arthritis Hub and the Lupus Hub

A vital element of comprehensive global IME delivery is our investment in international congress coverage.  

Together with our global steering committees, we identify key congresses that we would like to cover over a 12-month period. At the congresses, our medical writers attend as many sessions as possible and post live coverage to our social media feeds, sharing key data and news with our followers as soon as it is released. We provide congress digests, key updates, and live coverage over social media – ensuring we disseminate learning with our HCP communities, closing the learning gap for those who are not able to attend themselves. 

We are frequently the top influencer at congresses we attend for our current hubs. Being a top influencer means that of all the tweets surrounding the conference, ours are the ones with the most interaction. In this way, we are ensuring education is provided to the masses through our targeted tweets. 

This summer, our immunology hubs attended the 2023 European Alliance of Associations for Rheumatology (EULAR) Congress in Milan, Italy. During May 31 – June 3, over 12,000 delegates from around 125 countries met to share the latest scientific breakthroughs in clinical, translational, and basic sciences to guide treatment in rheumatic and musculoskeletal diseases. 

The dedicated coverage by our scientific teams secured an average of 1,989 impressions per post, with an engagement of 9.5%. Industry standards consider 0.5% to be a good engagement rate for Twitter, with anything above 1% seen as great – so to be hitting these metrics at such an early point in the platforms’ journeys is a testament to the quality and relevance of the content provided by the platforms. 

It was a quick turnaround for the Lupus Hub team to get back out to Milan for the 60th Annual European Renal Association (ERA) congress, June 15–18, 2023. With over 9,000 registrants from 123 countries, ERA showcased key lupus updates for coverage on the hub and boasted a daily Twitter audience of 16,000 HCPs. Securing up to 1,481 impressions per post, with an engagement rate of 7.3%, this was a key audience for the team to reach through the hub’s activities. 

The immunology team rounded off the summer with a longer flight to cover the key sessions at the World Congress of Dermatology (WCD), July 3–8, 2023, in Singapore. 

The congress, which runs every 4 years, aims to improve cooperation across geographic, political, and economic borders and improve skin health for all. The broad program covers clinical areas, community engagement, and research. 

Representatives from the SES partnerships team were delighted to attend in support of the scientific team to meet with key stakeholders in psoriasis, with a view to discuss the development and growth of the platform – both in terms of educational priorities and supporters. With over 12,000 attendees, there were lots of conversations to be had! 

For more information about our congress coverage plans or how you can support education in immunology, please contact our partnerships team.

Sign Up For Our Monthly Newsletter

Looking to receive the latest news, project updates, and new offerings?